ZBH
NYSE · Health Care
Zimmer Biomet Holdings Inc
$106.85
-3.30 (-3.00%)
Financial Highlights (FY 2026)
Revenue
7.88B
Net Income
674.75M
Gross Margin
69.7%
Profit Margin
8.6%
Rev Growth
+5.9%
D/E Ratio
0.59
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 69.7% | 69.7% | 64.1% | 64.1% |
| Operating Margin | 13.3% | 12.0% | 16.1% | 17.6% |
| Profit Margin | 8.6% | 8.1% | 12.9% | 12.9% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 7.88B | 7.44B | 6.31B | 5.01B |
| Gross Profit | 5.49B | 5.19B | 4.04B | 3.21B |
| Operating Income | 1.05B | 893.33M | 1.01B | 881.34M |
| Net Income | 674.75M | 573.71M | 811.29M | 646.00M |
| Gross Margin | 69.7% | 69.7% | 64.1% | 64.1% |
| Operating Margin | 13.3% | 12.0% | 16.1% | 17.6% |
| Profit Margin | 8.6% | 8.1% | 12.9% | 12.9% |
| Rev Growth | +5.9% | +5.9% | +10.6% | +15.9% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 3.34B | 3.34B | 1.44B | 1.31B |
| Total Equity | 5.64B | 5.64B | 14.61B | 14.13B |
| D/E Ratio | 0.59 | 0.59 | 0.10 | 0.09 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 1.69B | 1.51B | 1.21B | 980.03M |
| Free Cash Flow | — | — | 371.11M | 503.99M |